Brief: Ampio Updates Status Of Pivotal Clinical Trial Of Ampion To Be Carried Out Under A SPA
06/02/2019 13:34
Feb 6 (Reuters) - Ampio Pharmaceuticals Inc AMPE.A :
* AMPIO UPDATES STATUS OF PIVOTAL CLINICAL TRIAL OF AMPION
TO BE
CARRIED OUT UNDER A SPA
* AMPIO PHARMACEUTICALS - RECEIVED INITIAL RESPONSE FROM
U.S. FDA
REGARDING PROPOSED TRIAL DESIGN FOR TREATMENT OF KL4
OSTEOARTHRITIS PATIENTS WITH AMPION
Source text for Eikon: ID:nPnzWDgla
Further company coverage: AMPE.A
(Reuters.Briefs@thomsonreuters.com)
Recent news on Ampio Pharmaceuticals
See all newsBrief: Ampio Announces Voluntary Delisting And SEC Deregistration
Brief: Ampio Provides Update On Results From Pre-IND Enabling Studies
Brief: Ampio Selects Ascendia Pharmaceuticals, Inc. To Provide CDMO Services To Support Clinical Development Of OA-201
Brief: Ampio Pharmaceuticals Announces Reverse Stock Split
Brief: Ampio Pharmaceuticals Inc - Holds Approximately $1.25 Million In A Deposit Account At Silicon Valley Bank